|
1
|
Khadaroo RG, Churchill TA, Tso V, Madsen
KL, Lukowski C and Salim SY: Metabolomic profiling to characterize
acute intestinal ischemia/reperfusion injury. PLoS One.
12:e01793262017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang P, Liu D, Gan X, Zhang R, Gao W, Xia
Z and Hei Z: Mast cells activation contribute to small intestinal
ischemia reperfusion induced acute lung injury in rats. Injury.
43:1250–1256. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou J, Huang WQ, Li C, Wu GY, Li YS, Wen
SH, Lei WL and Liu KX: Intestinal ischemia/reperfusion enhances
microglial activation and induces cerebral injury and memory
dysfunction in rats. Crit Care Med. 40:2438–2448. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Grootjans J, Lenaerts K, Buurman WA,
Dejong CH and Derikx JP: Life and death at the mucosal-luminal
interface: New perspectives on human intestinal
ischemia-reperfusion. World J Gastroenterol. 22:2760–2770. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hwang YP and Jeong HG: Ginsenoside Rb1
protects against 6-hydroxydopamine-induced oxidative stress by
increasing heme oxygenase-1 expression through an estrogen
receptor-related PI3K/Akt/Nrf2-dependent pathway in human
dopaminergic cells. Toxicol Appl Pharmacol. 242:18–28. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peng Y, Li SN, Pei X and Hao K: The
multivariate regression statistics strategy to investigate
content-effect correlation of multiple components in traditional
Chinese medicine based on a partial least squares method.
Molecules. 23:E5452018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng Q, Bao XY, Zhu PC, Tong Q, Zheng GQ
and Wang Y: Ginsenoside Rb1 for myocardial ischemia/reperfusion
injury: Preclinical evidence and possible mechanisms. Oxid Med Cell
Longev. 2017:63136252017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu D, Zhang H, Gu W, Liu Y and Zhang M:
Neuroprotective effects of ginsenoside Rb1 on high glucose-induced
neurotoxicity in primary cultured rat hippocampal neurons. PLoS
One. 8:e793992013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xue X, Wang L, Meng X, Jiao J and Dang N:
Regulator of G protein signaling 4 inhibits human melanoma cells
proliferation and invasion through the PI3K/AKT signaling pathway.
Oncotarget. 8:78530–78544. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang L, Cao J, Cao L, Gao L, Yang Y and
Xu L: Puerarin induces cell apoptosis in human chondrosarcoma cell
line SW1353 via inhibition of the PI3K/Akt signaling pathway. Oncol
Lett. 14:5585–5590. 2017.PubMed/NCBI
|
|
11
|
Mellor P, Furber LA, Nyarko JN and
Anderson DH: Multiple roles for the p85α isoform in the regulation
and function of PI3K signalling and receptor trafficking. Biochem
J. 441:23–37. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ren M, Wang X, Du G, Tian J and Liu Y:
Calycosin-7-O-β-D-glucoside attenuates ischemia-reperfusion injury
in vivo via activation of the PI3K/Akt pathway. Mol Med Rep.
13:633–640. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang L, Yao Y, He R, Meng Y, Li N, Zhang
D, Xu J, Chen O, Cui J, Bian J, et al: Methane ameliorates spinal
cord ischemia-reperfusion injury in rats: Antioxidant,
anti-inflammatory and anti-apoptotic activity mediated by Nrf2
activation. Free Radic Biol Med. 103:69–86. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee YJ, Jeong HY, Kim YB, Lee YJ, Won SY,
Shim JH, Cho MK, Nam HS and Lee SH: Reactive oxygen species and
PI3K/Akt signaling play key roles in the induction of Nrf2-driven
heme oxygenase-1 expression in sulforaphane-treated human
mesothelioma MSTO-211H cells. Food Chem Toxicol. 50:116–123. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang R, Chae S, Lee JH and Hyun JW: The
cytoprotective effect of butin against oxidative stress is mediated
by the up-regulation of manganese superoxide dismutase expression
through a PI3K/Akt/Nrf2-dependent pathway. J Cell Biochem.
113:1987–1997. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ministry of Science and Technology of
China: Guideline on the humane treatment of laboratory animals.
2006.
|
|
17
|
Gan X, Liu D, Huang P, Gao W, Chen X and
Hei Z: Mast-cell-releasing tryptase triggers acute lung injury
induced by small intestinal ischemia-reperfusion by activating
PAR-2 in rats. Inflammation. 35:1144–1153. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhuang CL, Mao XY, Liu S, Chen WZ, Huang
DD, Zhang CJ, Chen BC, Shen X and Yu Z: Ginsenoside Rb1 improves
postoperative fatigue syndrome by reducing skeletal muscle
oxidative stress through activation of the PI3K/Akt/Nrf2 pathway in
aged rats. Eur J Pharmacol. 740:480–487. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Z, Ye Z, Huang G, Wang N, Wang E and
Guo Q: Sevoflurane post-conditioning enhanced hippocampal neuron
resistance to global cerebral ischemia induced by cardiac arrest in
rats through PI3K/Akt survival pathway. Front Cell Neurosci.
10:2712016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Petrat F, Swoboda S, de Groot H and
Schmitz KJ: Quantification of ischemia-reperfusion injury to the
small intestine using a macroscopic score. J Invest Surg.
23:208–217. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang Y, Zhou Z, Meng QT, Sun Q, Su W, Lei
S, Xia Z and Xia ZY: Ginsenoside Rb1 treatment attenuates pulmonary
inflammatory cytokine release and tissue injury following
intestinal ischemia reperfusion injury in mice. Oxid Med Cell
Longev. 2015:8437212015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cui YC, Pan CS, Yan L, Li L, Hu BH, Chang
X, Liu YY, Fan JY, Sun K, -Li Q and Han JY: Ginsenoside Rb1
protects against ischemia/reperfusion-induced myocardial injury via
energy metabolism regulation mediated by RhoA signaling pathway.
Sci Rep. 7:445792017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xun W, Shi L, Zhou H, Hou G, Cao T and
Zhao C: Effects of curcumin on growth performance, jejunal mucosal
membrane integrity, morphology and immune status in weaned piglets
challenged with enterotoxigenic Escherichia coli. Int
Immunopharmacol. 27:46–52. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tornai T, Palyu E, Vitalis Z, Tornai I,
Tornai D, Antal-Szalmas P, Norman GL, Shums Z, Veres G, Dezsofi A,
et al: Gut barrier failure biomarkers are associated with poor
disease outcome in patients with primary sclerosing cholangitis.
World J Gastroenterol. 23:5412–5421. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin ZL, Tan SJ, Cheng MH, Zhao CY, Yu WK,
He YL, Li J and Li N: Lipid-rich enteral nutrition controls
intestinal inflammation, improves intestinal motility and mucosal
barrier damage in a rat model of intestinal ischemia/reperfusion
injury. J Surg Res. 213:75–83. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ge M, Gan X, Liu D, Zhang W, Gao W, Huang
P and Hei Z: Time-course analysis of counts and degranulation of
mast cells during early intestinal ischemia-reperfusion injury in
mice. Mol Med Rep. 8:401–406. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao W, Zhou S, Yao W, Gan X, Su G, Yuan D
and Hei Z: Propofol prevents lung injury after intestinal
ischemia-reperfusion by inhibiting the interaction between mast
cell activation and oxidative stress. Life Sci. 108:80–87. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Takayama G, Ohtani M, Minowa A, Matsuda S
and Koyasu S: Class I PI3K-mediated Akt and ERK signals play a
critical role in FcεRI-induced degranulation in mast cells. Int
Immunol. 25:215–220. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kai-lan W and Si Z: Pretreatment with
erythropoietin attenuates intestinal ischemia reperfusion injury by
further promoting PI3K/Akt signaling activation. Transplant Proc.
47:1639–1645. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim JH, Kim J, Chun J, Lee C, Im JP and
Kim JS: Role of iRhom2 in intestinal ischemia-reperfusion-mediated
acute lung injury. Sci Rep. 8:37972018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu D, Gan X, Huang P, Chen X, Ge M and
Hei Z: Inhibiting tryptase after ischemia limits small intestinal
ischemia-reperfusion injury through protease-activated receptor 2
in rats. J Trauma Acute Care Surg. 73:1138–1144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mancuso C and Santangelo R: Panax ginseng
and Panax quinquefolius: From pharmacology to toxicology. Food Chem
Toxicol. 107:362–372. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cheng Z and Li L: Ginsenoside Rg3
ameliorates lipopolysaccharide-induced acute lung injury in mice
through inactivating the nuclear factor-κB (NF-κB) signaling
pathway. Int Immunopharmacol. 34:53–59. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tan S, Yu W, Lin Z, Chen Q, Shi J, Dong Y,
Duan K, Bai X, Xu L, Li J and Li N: Anti-inflammatory effect of
ginsenoside Rb1 contributes to the recovery of gastrointestinal
motility in the rat model of postoperative ileus. Biol Pharm Bull.
37:1788–1794. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li Y, Tang J, Khatibi NH, Zhu M, Chen D,
Tu L, Chen L and Wang S: Treatment with ginsenoside rb1, a
component of panax ginseng, provides neuroprotection in rats
subjected to subarachnoid hemorrhage-induced brain injury. Acta
Neurochir Suppl. 110:75–79. 2011.PubMed/NCBI
|
|
36
|
Tan S, Zhou F, Li N, Dong Q, Zhang X, Ye
X, Guo J, Chen B and Yu Z: Anti-fatigue effect of ginsenoside Rb1
on postoperative fatigue syndrome induced by major small intestinal
resection in rat. Biol Pharm Bull. 36:1634–1639. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li G, Qian W and Zhao C: Analyzing the
anti-ischemia-reperfusion injury effects of ginsenoside Rb1
mediated through the inhibition of p38α MAPK. Can J Physiol
Pharmacol. 94:97–103. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun Q, Meng QT, Jiang Y and Xia ZY:
Ginsenoside Rb1 attenuates intestinal ischemia reperfusion induced
renal injury by activating Nrf2/ARE pathway. Molecules.
17:7195–7205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen T, Xue H, Lin R and Huang Z: MiR-126
impairs the intestinal barrier function via inhibiting S1PR2
mediated activation of PI3K/AKT signaling pathway. Biochem Biophys
Res Commun. 494:427–432. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhao LL, Hu GC, Zhu SS, Li JF and Liu GJ:
Propofol pretreatment attenuates lipopolysaccharide-induced acute
lung injury in rats by activating thephosphoinositide-3-kinase/Akt
pathway. Braz J Med Biol Res. 47:1062–1067. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nier A, Engstler AJ, Maier IB and Bergheim
I: Markers of intestinal permeability are already altered in early
stages of non-alcoholic fatty liver disease: Studies in children.
PLoS One. 12:e01832822017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li H, Chen Y, Huo F, Wang Y and Zhang D:
Association between acute gastrointestinal injury and biomarkers of
intestinal barrier function in critically ill patients. BMC
Gastroenterol. 17:452017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Guo YY, Liu ML, He XD, Jiang CQ and Liu
RL: Functional changes of intestinal mucosal barrier in surgically
critical patients. World J Emerg Med. 1:205–208. 2010.PubMed/NCBI
|
|
44
|
Jin X, Yu CH, Lv GC and Li YM: Increased
intestinal permeability in pathogenesis and progress of
nonalcoholic steatohepatitis in rats. World J Gastroenterol.
13:1732–1736. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Song WB, Lv YH, Zhang ZS, Li YN, Xiao LP,
Yu XP, Wang YY, Ji HL and Ma L: Soluble intercellular adhesion
molecule-1, D-lactate and diamine oxidase in patients with
inflammatory bowel disease. World J Gastroenterol. 15:3916–3919.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Uramatsu M, Matsumoto T, Tateda K, Shibuya
K, Miyazaki S, Horino T, Tanabe M, Sumiyama Y, Kusachi S and
Yamaguchi K: Involvement of endotoxin in the mortality of mice with
gut-derived sepsis due to methicillin-resistant Staphylococcus
aureus. Microbiol Immunol. 54:330–337. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yuan DD, Chi XJ, Jin Y, Li X, Ge M, Gao
WL, Guan JQ, Zhang AL and Hei ZQ: Intestinal injury following liver
transplantation was mediated by TLR/NF-ĸB activation-induced cell
apoptosis. Mol Med Rep. 13:1525–1532. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Onal O, Yetisir F, Sarer AE, Zeybek ND,
Onal CO, Yurekli B, Celik HT, Sirma A and Kılıc M: Prophylactic
ozone administration reduces intestinal mucosa injury induced by
intestinal ischemia-reperfusion in the rat. Mediators Inflamm.
2015:7920162015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhao W, Gan X, Su G, Wanling G, Li S, Hei
Z, Yang C and Wang H: The interaction between oxidative stress and
mast cell activation plays a role in acute lung injuries induced by
intestinal ischemia-reperfusion. J Surg Res. 187:542–552. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Scott JR, Cukiernik MA, Ott MC, Bihari A,
Badhwar A, Gray DK, Harris KA, Parry NG and Potter RF: Low-dose
inhaled carbon monoxide attenuates the remote intestinal
inflammatory response elicited by hindlimb ischemia-reperfusion. Am
J Physiol Gastrointest Liver Physiol. 296:G9–G14. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liu ZQ: Chemical insights into ginseng as
a resource for natural antioxidants. Chem Rev. 112:3329–3355. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Oh SJ, Kim K and Lim CJ: Protective
properties of ginsenoside Rb1 against UV-B radiation-induced
oxidative stress in human dermal keratinocytes. Pharmazie.
70:381–387. 2015.PubMed/NCBI
|
|
53
|
Huang CY, Hsiao JK, Lu YZ, Lee TC and Yu
LC: Anti-apoptotic PI3K/Akt signaling by sodium/glucose transporter
1 reduces epithelial barrier damage and bacterial translocation in
intestinal ischemia. Lab Invest. 91:294–309. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yin X, Wang X, Fan Z, Peng C, Ren Z, Huang
L, Liu Z and Zhao K: Hyperbaric oxygen preconditioning attenuates
myocardium ischemia-reperfusion injury Through upregulation of heme
oxygenase 1 expression: PI3K/Akt/Nrf2 pathway involved. J
Cardiovasc Pharmacol Ther. 20:428–438. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang J, Yao Y, Xiao F, Lan X, Yu C, Zhang
Y, Jiang C, Yang J, Pei G, Li Y, et al: Administration of
dexamethasone protects mice against ischemia/reperfusion induced
renal injury by suppressing PI3K/AKT signaling. Int J Clin Exp
Pathol. 6:2366–2375. 2013.PubMed/NCBI
|
|
56
|
Zhu J, Chen X, Wang H and Yan Q: Catalpol
protects mice against renal ischemia/reperfusion injury via
suppressing PI3K/Akt-eNOS signaling and inflammation. Int J Clin
Exp Med. 8:2038–2044. 2015.PubMed/NCBI
|
|
57
|
Oudit GY, Sun H, Kerfant BG, Crackower MA,
Penninger JM and Backx PH: The role of phosphoinositide-3 kinase
and PTEN in cardiovascular physiology and disease. J Mol Cell
Cardiol. 37:449–471. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Li W, Ma F, Zhang L, Huang Y, Li X, Zhang
A, Hou C and Zhu Y and Zhu Y: S-Propargyl-cysteine exerts a novel
protective effect on methionine and choline deficient diet-induced
fatty liver via Akt/Nrf2/HO-1 pathway. Oxid Med Cell Longev.
2016:46908572016. View Article : Google Scholar : PubMed/NCBI
|
